The 3 analysts offering 12-month price forecasts for Lexicon Pharmaceuticals Inc have a median target of 3.00, with a high estimate of 10.00 and a low estimate of 2.30. The median estimate represents a +63.93% increase from the last price of 1.83.
The current consensus among 6 polled investment analysts is to Hold stock in Lexicon Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.69
Reporting Date Apr 29
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.